Professional Documents
Culture Documents
HCSII
You are asked to develop an analytical method for a lipophilic molecule of molecule
weight 299 for use as part of clinical trial. You have the option of developing either an
immunoassay based or chromatography based method. Discuss the relative merits of
each assay.
1. Introduction
Crucial to the success of any clinical trial is the careful development of analytical
methods with which to measure analytes of interest. The theoretical trial discussed here
involves a small lipophilic molecule of molecular weight 299. This could be for example, a
new drug being developed by a pharmaceutical company or a human steroid being
investigated in a clinical trial involving hormonal pathways. Any analytical technique
used in such a study would therefore have to identify and quantify the analyte in order
for the clinical trial to progress (Riley and Rosanske 1996).
There are many types of analytical method which can be used to quantify small
lipophilic molecules. Factors such as the scale and time frame of a trial will affect the
exact methodology chosen, as large scale trials set over a short space of time will
require a high-throughput mode of analysis. Any method developed for a trial may later
require scaling up if the drug or analyte is deemed fit for clinical use. It is therefore
advantageous if the method developed is suited to large scale analyses. Chromatography
and immunoassays are both commonly used in the analysis of small molecular weight
molecules. There are numerous variations of each method, and each has its advantages
and disadvantages for particular analyses.
2. Immunoassays
Immunoassay techniques were first described in 1959 and have since become a vital
analytical tool in science and medicine (Yalow and Berson 1959; Wild 2001).
Immunoassays exploit the ability of antibodies to bind tightly and specifically to a wide
range of target molecules. They generate a signal of certain intensity dependent on the
concentration of their target analyte. The requirements of a standard immunoassay are
listed in table 1 (Wheeler and Morley Hutchinson 2006). Immunoassays can vary in
complexity from simple single step turbidimetry assays to more complex immunoassays
involving a separation step between the formation of complexes and the measurement of
signal (heterogeneous assays) (Wild 2001).
Figure 1. The principles of
A
competitive (A) and sandwich (B)
assays. A. Competitive assays involve
the competition for binding between
labelled exogenous analyte and
endogenous with an intermediate
wash step. Signal is stronger the less
endogenous analyte is present, as
more sites are taken up by labelled
B
analyte. B. Sandwich assays involve
the formation of Ab:Ag:Ab sandwich
complexes. Signal increases with
analyte concentration.
Basic Requirements of an Immunoassay
3. Chromatography
4. Immunoassay or Chromatography?
Whilst generally fast and easily automatable once established, the use of an
immunoassay for a small lipophilic molecule will be complicated by the often extreme
difficulty of raising an antibody to such an analyte. The small size of the analyte in
question limits the number of epitopes available for target and may mean that it evades
the immune system altogether. Larger immunogenic carrier molecules such as Keyhole
limpet hemocyanin (KLH) can be chemically joined to small molecules (haptens) in order
to elicit an immune response and produce useable immunoglobulins. The antibodies
produced can often be targeted to the carrier protein and not to the hapten of interest
(Pastor-Navarro, 2007, Singh KV, 2010). If suitable antibody is produced, then a
competitive (direct) immunoassay is often the preferred method for small molecules
(<1000MW) rather than sandwich assays as only one antibody is required to bind even
though sandwich assays are typically more sensitive and specific than competitive
assays (Ekins 1980; Quinton, Charruault et al. 2010). Two antibodies targeted to the
same 299 molecular weight molecule will result in steric hindrance due to the limited
space on the 299 MW analyte to accommodate both immunoglobulins at once. There is
little limitation in the size of analytes that can be separated and quantitated using
chromatography. GC/MS is routinely used for the analysis of alcohols which are typically
less than 100MW (Szczepaniak and Isidorov 2011). For a small lipophilic compound as
described in this theoretical trial, the use of reverse phase HPLC chromatography in
which a nonpolar stationary phase such as C18 is used could provide sufficient
separation once important parameters such as mobile phase composition and optimal
temperature are deduced. The wide range of variables which can be altered in such an
analysis can greatly enhance the sensitivity of chromatographic methods and whilst
there is often an element of trial and error in such assay design, chromatographic assay
development can be relatively fast compared to immunoassay.
The hook effect can occur when antigen is in excess to antibody and all binding sites on
the antibody saturate with endogenous analyte preventing labelled analyte binding and
creating a signal (Miller 2004). Modern analysers therefore often perform automatic
dilutions on samples with abnormally low results. Antibodies in immunoassays are often
not specific enough to target only the analyte of interest. Steroid hormones for example,
are particularly difficult to analyse by immunoassay due to potential cross reactivity of
antibodies to similarly structured steroids (Fitzgerald and Herold 1996; Wood, Ducroq et
al. 2008) (see fig 2A). In the case of cortisol, chromatography techniques are generally
thought to be the most accurate as several immunological methods for the detection of
urine free cortisol are known to cross react with the cortisol precursor 11-hydroxycortisol
resulting in over or under estimation of cortisol levels (see fig 2B) (De Brabandere, LM et
al. 1995). Steroid hormone immunoassays often perform poorly in assays requiring very
low detection limits for a medical application such as male estradiol measurements
(Potischman, Falk et al. 1994). In general such immunoassays perform well over higher
concentration ranges with sufficient inter and intra-assay variations for routine, high
throughput use (CV 10-15%)(Taieb, Benattar et al. 2002). HPLC and GC/MS are not
affected by cross reactivity.
A B
Fig 2. Immunoassays suffer from interference from similarly structured molecules in the sample
matrix. A, The steroid hormones have similar structures which contain four characteristic
cycloalkane rings. It is therefore difficult to distinguish between them using antibodies and over estimation
of individual hormone concentrations is common. B, a study of analytical methods for measuring urine free
cortisol showed that immunoassays often over or under estimate compared to more sensitive and specific
HPLC methods (Turpeinen, Markkanen et al. 1997).
5. Conclusion: